Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

CANCER:

Thyroid Gland Anaplastic Carcinoma

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related cancers:

‹

Thyroid Gland Carcinoma (359)

Thyroid Gland Medullary Carcinoma (61)

Thyroid Gland Papillary Carcinoma (58)

Thyroid Gland Follicular Carcinoma (25)

Thyroid Gland Oncocytic Carcinoma (12)

Thyroid Gland Carcinoma (359)

Thyroid Gland Medullary Carcinoma (61)

Thyroid Gland Papillary Carcinoma (58)

Thyroid Gland Follicular Carcinoma (25)

Thyroid Gland Oncocytic Carcinoma (12)

›

BRAF V600E	Thyroid Gland Anaplastic Carcinoma	BRAF V600E	Thyroid Gland Anaplastic Carcinoma	trametinib + dabrafenib Sensitive: A1 - Approval trametinib + dabrafenib Sensitive : A1	trametinib + dabrafenib Sensitive: A1 - Approval trametinib + dabrafenib Sensitive : A1
BRAF V600E	Thyroid Gland Anaplastic Carcinoma	BRAF V600E	Thyroid Gland Anaplastic Carcinoma	dabrafenib Sensitive: A1 - Approval dabrafenib Sensitive : A1	dabrafenib Sensitive: A1 - Approval dabrafenib Sensitive : A1
No biomarker	Thyroid Gland Anaplastic Carcinoma	No biomarker	Thyroid Gland Anaplastic Carcinoma	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Thyroid Gland Anaplastic Carcinoma	No biomarker	Thyroid Gland Anaplastic Carcinoma	cisplatin Sensitive: A2 - Guideline cisplatin Sensitive : A2	cisplatin Sensitive: A2 - Guideline cisplatin Sensitive : A2
No biomarker	Thyroid Gland Anaplastic Carcinoma	No biomarker	Thyroid Gland Anaplastic Carcinoma	docetaxel + doxorubicin hydrochloride Sensitive: A2 - Guideline docetaxel + doxorubicin hydrochloride Sensitive : A2	docetaxel + doxorubicin hydrochloride Sensitive: A2 - Guideline docetaxel + doxorubicin hydrochloride Sensitive : A2
No biomarker	Thyroid Gland Anaplastic Carcinoma	No biomarker	Thyroid Gland Anaplastic Carcinoma	doxorubicin hydrochloride Sensitive: A2 - Guideline doxorubicin hydrochloride Sensitive : A2	doxorubicin hydrochloride Sensitive: A2 - Guideline doxorubicin hydrochloride Sensitive : A2
No biomarker	Thyroid Gland Anaplastic Carcinoma	No biomarker	Thyroid Gland Anaplastic Carcinoma	paclitaxel Sensitive: A2 - Guideline paclitaxel Sensitive : A2	paclitaxel Sensitive: A2 - Guideline paclitaxel Sensitive : A2
NTRK3 fusion	Thyroid Gland Anaplastic Carcinoma	NTRK3 fusion	Thyroid Gland Anaplastic Carcinoma	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2
NTRK2 fusion	Thyroid Gland Anaplastic Carcinoma	NTRK2 fusion	Thyroid Gland Anaplastic Carcinoma	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2
NTRK1 fusion	Thyroid Gland Anaplastic Carcinoma	NTRK1 fusion	Thyroid Gland Anaplastic Carcinoma	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2
NTRK1 fusion	Thyroid Gland Anaplastic Carcinoma	NTRK1 fusion	Thyroid Gland Anaplastic Carcinoma	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2
NTRK2 fusion	Thyroid Gland Anaplastic Carcinoma	NTRK2 fusion	Thyroid Gland Anaplastic Carcinoma	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2